Viking Therapeutics Inc (VKTX)

05:56 AM

Viking Therapeutics (VKTX) Prepares to Announce Q1 Earnings - GuruFocus

05:56 AM

05:16 AM

Viking Therapeutics stock price target cut to $100 by Oppenheimer - Investing.com

05:16 AM

09:30 AM

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

09:30 AM

04:19 AM

Viking Therapeutics Sets Sights on Recovery With Focus on Obesity Drug - Investing.com

04:19 AM

Apr 21, 2025

Is Viking Therapeutics Stock (VKTX) Nearing A Bottom? - See It Market

Apr 21, 2025

Apr 21, 2025

Viking Therapeutics to Report Q1 Earnings: What's in the Cards? - Zacks Investment Research

Apr 21, 2025

Apr 20, 2025

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know - MSN

Apr 20, 2025

Apr 19, 2025

(VKTX) Trading Signals - news.stocktradersdaily.com

Apr 19, 2025

Apr 18, 2025

Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735 - Yahoo Finance

Apr 18, 2025

Apr 18, 2025

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data - Yahoo Finance

Apr 18, 2025

Apr 18, 2025

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics - Yahoo Finance

Apr 18, 2025

Apr 17, 2025

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics (VKTX) Gains Attention with Promising Diabetes Treatment | LLY Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

2 Stocks Down by 25% or More This Year to Buy and Hold - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics: A Lot More Compelling After The MeltdownInitiating Cautious Buy (Rating Upgrade) - Seeking Alpha

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics (VKTX) Shares Surge on Pfizer's Decision - GuruFocus

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics (VKTX) to Announce Q1 2025 Financial Results - GuruFocus

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics Inc (VKTX) Stock Price, Trades & News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics (VKTX) Shares Decline Following Eli Lilly's Phase 3 Results | LLY Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Viking Therapeutics slips after Eli Lilly reports orforglipron trial results - TipRanks

Apr 17, 2025

Apr 16, 2025

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025 - Quantisnow

Apr 16, 2025

Apr 16, 2025

Viking Therapeutics to Report Financial Results for First Quarte - GuruFocus

Apr 16, 2025

Apr 16, 2025

Viking Therapeutics Sets Q1 Earnings Date: Key Updates Expected on Metabolic Drug Pipeline - Stock Titan

Apr 16, 2025

Apr 16, 2025

Viking Therapeutics Stock Pops But Struggles to Hold Gains - MarketBeat

Apr 16, 2025

Apr 16, 2025

Viking Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VKTX - Benzinga

Apr 16, 2025

Apr 15, 2025

Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market - Seeking Alpha

Apr 15, 2025

Apr 15, 2025

Will Pfizer approach Viking Therapeutics with a buyout proposal? - TradingView

Apr 15, 2025

Apr 15, 2025

Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (NASDAQ:VKTX) - Seeking Alpha

Apr 15, 2025

Apr 15, 2025

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock? - MSN

Apr 15, 2025

Apr 15, 2025

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback - Zacks Investment Research

Apr 15, 2025

Apr 15, 2025

Viking Therapeutics (VKTX) Surges as Pfizer Halts Obesity Drug - GuruFocus

Apr 15, 2025

Apr 15, 2025

Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday? - MSN

Apr 15, 2025

Apr 14, 2025

Director Foehr Matthew W exercised 20,786 shares at a strike of $8.00, increasing direct ownership by 19% to 132,036 units (SEC Form 4) - Quantisnow

Apr 14, 2025

Apr 14, 2025

Pfizer Abandons Obesity Pill After Liver Injury in Setback - Bloomberg.com

Apr 14, 2025

Apr 14, 2025

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today - The Globe and Mail

Apr 14, 2025

Apr 14, 2025

Pfizer's $130B Weight-Loss Dream Just Collapsed - Yahoo Finance

Apr 14, 2025

Apr 14, 2025

Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) - Seeking Alpha

Apr 14, 2025

Apr 14, 2025

What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday? - Benzinga

Apr 14, 2025

Apr 14, 2025

Biotech Stock A Big Winner After Pfizer Halts Weight-Loss Drug - Schaeffer's Investment Research

Apr 14, 2025

Apr 14, 2025

Viking Therapeutics shares surge on Pfizer’s drug discontinuation By Investing.com - Investing.com India

Apr 14, 2025

Apr 14, 2025

Viking Therapeutics shares surge on Pfizer’s drug discontinuation - Investing.com

Apr 14, 2025

Apr 12, 2025

3 Magnificent Stocks That Could Double or More by 2030 - Yahoo Finance

Apr 12, 2025

Apr 10, 2025

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years? - Yahoo

Apr 10, 2025

Apr 08, 2025

Viking Therapeutics stock hits 52-week low at $20.26 - Investing.com Australia

Apr 08, 2025

Apr 08, 2025

Viking Therapeutics stock hits 52-week low at $20.26 By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

Goldman Sachs Initiates Coverage of Viking Therapeutics (VKTX) with Neutral Recommendation - Nasdaq

Apr 08, 2025

Apr 08, 2025

Amendment: Director Rouan Sarah Kathryn bought $29,943 worth of shares (1,240 units at $24.15) (SEC Form 4) - Quantisnow

Apr 08, 2025

Apr 08, 2025

Goldman Sachs Initiates Coverage on Viking Therapeutics (VKTX) w - GuruFocus

Apr 08, 2025

Apr 08, 2025

Viking Therapeutics draws Neutral rating at Goldman Sachs on competitive headwinds - Seeking Alpha

Apr 08, 2025

Apr 08, 2025

Goldman initiated coverage on Viking Therapeutics with a new price target - Quantisnow

Apr 08, 2025

Apr 08, 2025

Goldman Sachs Initiates Viking Therapeutics With Neutral Rating, $30 Price Target - MarketScreener

Apr 08, 2025

Apr 08, 2025

Goldman Sachs sets Viking Therapeutics stock at Neutral By Investing.com - Investing.com Canada

Apr 08, 2025